Tadatoshi Takayama

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 276 publications

Morphological changes in the muscle layer associated with invasion of bladder cancer.

Morphological changes in the muscle layer associated with invasion of bladder cancer.

Journal: Clinical radiology

Published: October 23, 2024

Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study.

Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study.

Journal: Annals of gastroenterological surgery

Published: October 21, 2024

Correction: Comparison between CT volumetry and extracellular volume fraction using liver dynamic CT for the predictive ability of liver fibrosis in patients with hepatocellular carcinoma.

Correction: Comparison between CT volumetry and extracellular volume fraction using liver dynamic CT for the predictive ability of liver fibrosis in patients with hepatocellular carcinoma.

Journal: European radiology

Published: June 18, 2024

MR elastography vs a combination of common non-invasive tests for estimation of severe liver fibrosis in patients with hepatobiliary tumors.

MR elastography vs a combination of common non-invasive tests for estimation of severe liver fibrosis in patients with hepatobiliary tumors.

Journal: European radiology

Published: March 07, 2024

Comparison between Intravoxel Incoherent Motion and Splenic Volumetry to Predict Hepatic Fibrosis Staging in Preoperative Patients.

Comparison between Intravoxel Incoherent Motion and Splenic Volumetry to Predict Hepatic Fibrosis Staging in Preoperative Patients.

Journal: Diagnostics (Basel, Switzerland)

Published: August 31, 2023

The significance of CDT1 expression in non-cancerous and cancerous liver in cases with hepatocellular carcinoma.

The significance of CDT1 expression in non-cancerous and cancerous liver in cases with hepatocellular carcinoma.

Journal: Journal of clinical biochemistry and nutrition

Published: May 29, 2023

Extracellular volume by dual-energy CT, hepatic reserve capacity scoring, CT volumetry, and transient elastography for estimating liver fibrosis.

Extracellular volume by dual-energy CT, hepatic reserve capacity scoring, CT volumetry, and transient elastography for estimating liver fibrosis.

Journal: Scientific reports

Published: May 20, 2023

Impact of Tumor Shrinkage Pattern with Biweekly Triplet Gemcitabine+Cisplatin+S-1 Regimen for Biliary Tract Cancers: Implications for Neoadjuvant Therapy from the Data of KHBO1401 (KHBO1401-1A Study).

Impact of Tumor Shrinkage Pattern with Biweekly Triplet Gemcitabine+Cisplatin+S-1 Regimen for Biliary Tract Cancers: Implications for Neoadjuvant Therapy from the Data of KHBO1401 (KHBO1401-1A Study).

Journal: Oncology

Published: May 16, 2023

Clinicopathological Examination of Resected Case of Primary Duodenal Cancer at Our Hospital

Clinicopathological Examination of Resected Case of Primary Duodenal Cancer at Our Hospital

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 03, 2023

A 10-Year Survivor with Multidisciplinary Treatment for Pancreatic Carcinoma That Recurred 17 Months after Pancreatoduodenectomy

A 10-Year Survivor with Multidisciplinary Treatment for Pancreatic Carcinoma That Recurred 17 Months after Pancreatoduodenectomy

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 03, 2023

Comparison between CT volumetry, technetium99m galactosyl-serum-albumin scintigraphy, and gadoxetic-acid-enhanced MRI to estimate the liver fibrosis stage in preoperative patients.

Comparison between CT volumetry, technetium99m galactosyl-serum-albumin scintigraphy, and gadoxetic-acid-enhanced MRI to estimate the liver fibrosis stage in preoperative patients.

Journal: European radiology

Published: October 19, 2022

Clinical outcomes of second‑line chemotherapy after gemcitabine and cisplatin plus S‑1 treatment for patients with advanced biliary tract cancer in the KHBO1401‑3A study.

Clinical outcomes of second‑line chemotherapy after gemcitabine and cisplatin plus S‑1 treatment for patients with advanced biliary tract cancer in the KHBO1401‑3A study.

Journal: Oncology reports

Published: October 13, 2022

Showing 1-12 of 276

Last Updated: 09/26/2026